Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.52 |
| ▸ | TSHR | P16473 | 5/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 4/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.52 |
| ▸ | TP53 | P04637 | 3/20 | 0.48 |
| ▸ | GAA | P10253 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | HPGD | P15428 | 2/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | GLA | P06280 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | KIF11 | P52732 | 1/20 | 0.48 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.47 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL146321 | 0.93 | ALDH1A1 (0.61) | ALDH1A1TSHRALOX15HSD17B10MAPT | |
| Hydrochloric Acid SCHEMBL9693558 | 0.90 | ALDH1A1 (0.58) | ALDH1A1TSHRALOX15HSD17B10MAPT | |
| Hydrochloric Acid SCHEMBL10664947 | 0.90 | ALDH1A1 (0.58) | ALDH1A1TSHRALOX15HSD17B10MAPT | |
| SCHEMBL9694680 | 0.82 | ALDH1A1 (0.70) | ALDH1A1TSHRALOX15HSD17B10MAPT | |
| SCHEMBL11547412 | 0.82 | ALDH1A1 (0.79) | ALDH1A1TSHRALOX15HSD17B10MAPT | |
| SCHEMBL124209 | 0.82 | ALDH1A1 (0.79) | ALDH1A1TSHRALOX15HSD17B10MAPT | |
| SCHEMBL5147226 | 0.82 | KIF11 (0.64) | ALDH1A1TSHRALOX15HSD17B10MAPT | |
| SCHEMBL5982666 | 0.80 | MAPK1 (0.61) | ALDH1A1TSHRALOX15HSD17B10MAPT | |
| Hydrochloric Acid SCHEMBL5319951 | 0.80 | ALDH1A1 (0.71) | ALDH1A1TSHRALOX15HSD17B10MAPT | |
| SCHEMBL9627045 | 0.80 | SLC2A1 (0.55) | ALDH1A1TSHRALOX15HSD17B10MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1553985-B1 | BIPHENYLS AS IMAGING AGENTS IN ALZHEIMER'S DISEASE | UNIV PENNSYLVANIA (US) | 2011-08-31 | — | — | EP | disclosed |
| US-20070254889-A1 | Compounds and methods useful for rescuing cells from beta-amyloid toxicity and treatment of Alzheimer's disease | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 2007-11-01 | — | — | US | disclosed |
| US-20050271584-A1 | Biphenyls and fluorenes as imaging agents in alzheimer's disease | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2005-12-08 | — | — | US | disclosed |
| EP-1553985-A2 | BIPHENYLS AND FLUORENES AS IMAGING AGENTS IN ALZHEIMER'S DISEASE | The Trustees of The University of Pennsylvania (US) | 2005-07-20 | — | — | EP | disclosed |
| WO-2004032975-A2 | BIPHENYLS AND FLUORENES AS IMAGING AGENTS IN ALZHEIMER'S DISEASE | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2004-04-22 | — | — | WO | disclosed |
| EP-0995786-B1 | Electrochromic device | NIPPON MITSUBISHI OIL CORP (JP) | 2003-01-08 | — | — | EP | disclosed |
| US-6208452-B1 | HAS AN ION CONDUCTIVE LAYER OBTAINED BY CURING A COMPOSITION COMPRISING A BIPYRIDINIUM COMPOUND, A SPECIFIC AMINE COMPOUND AND A PRECURSOR COMPONENT OF A POLYMERIC SOLID ELECTROLYTE DISPOSED BETWEEN TWO ELECTRICALLY CONDUCTIVE SUBSTRATES | NIPPON MITSUBISHI OIL CORPORATION (JP) | 2001-03-27 | — | — | US | disclosed |
| US-6203154-B1 | MULTILAYER | NIPPON MITSUBISHI OIL CORPORATION (JP) | 2001-03-20 | — | — | US | disclosed |
| EP-1041425-A1 | ELECTROCHROMIC ELEMENT | Nippon Mitsubishi Oil Corporation (JP) | 2000-10-04 | — | — | EP | disclosed |
| EP-0995786-A1 | Electrochromic device | Nippon Mitsubishi Oil Corporation (JP) | 2000-04-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070254889-A1 | Compounds and methods useful for rescuing cells from beta-amyloid toxicity and treatment of Alzheimer's disease | APP, BACE1, IAPP | ALDH1A1 1209/4885TSHR 4786/4885ALOX15 1916/4885 |
| US-20050271584-A1 | Biphenyls and fluorenes as imaging agents in alzheimer's disease | APP, BACE2, BACE1 | ALDH1A1 1533/4885TSHR 3575/4885ALOX15 2100/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.